Ventrix provides solutions for the heart. Ventrix, Inc. is a privately held company and has established a firm foothold in San Diego, CA. Ventrix is current enrolling a Phase 1 clinical study. In 2012, Ventrix closed a Series A financing round and has received funding from NIH and NSF SBIR awards.
Ventrix is focused on delivering a biomaterial scaffold for cardiac repair for heart failure patients who currently have very limited treatment options. Ventrix is interested in partnership opportunities with leading Healthcare Technology companies. If you are interested in a partnership or investment opportunity with Ventrix, please contact us here.